BPC-157 alternatives that have stronger evidence for recovery are listed below
Changes in Appetite There are anecdotal accounts of increased or decreased appetite, though this varies from person to person and isnt widely documented in clinical studies
NICOTINAMIDE (NAM), NAD+ PRECURSOR: The NAMPT salvage pathway that converts nicotinamide to NAD+ represents the major route to NAD+ biosynthesis in mammals
In some embodiments, the lipid-based drug delivery formulation is a phospholipid-based formulation (e.g., hydrogenated or nonhydrogenated phospholipids, lecithins, phosphatidyl cholines (C8-C18), phosphatidylethanolamines (C8-C18), phosphatidylglycerols (C8-C18)) wherein the phospholipid is phospholipon 90H (1,2-dia-cyl-SN-glycero-3-phosphatidyl choline), egg phospholipids P123, Lipoid E80
Again, the peptide was observed to potentially increase skin density and thickness
SPARC is primarily expressed during embryonic development or in the course of tissue healing and remodeling [9]